Transforming growth β (TGF‐β) has been proposed to have a role in bone remodeling by affecting the differentiation and activity of osteoblasts and osteoclasts and by inhibiting the production of proteinases, such as plasminogen activators (PAs). Studies on PAs have largely been based on data from nonhuman and fetal cell lines, however. The purpose of this study was to investigate the effect of TGF‐β on the PA activity of normal human osteoblast‐like cells and to compare this with its action on the human osteosarcoma cell line MG‐63. The action of interleukin‐1β (IL‐1β) was also assessed because it has been shown to increase PA activity in other connective tissue cell types. Normal osteoblast‐like cells had low to undetectable basal urokinase (uPA) and tissue plasminogen activator (tPA) activity, which was significantly stimulated by TGF‐β1. This action was shown to be dependent on transcription and new protein synthesis. TGY‐β2 had a similar action. IL‐1β did not stimulate PA activity. In contrast, the MG‐63 cell line had high basal tPA and uPA activities. TGF‐β1 decreased basal PA activity, the effect being most marked for uPA activity. IL‐1β stimulated uPA and tPA activity. TGF‐β1 inhibited IL‐1β‐stimulated uPA activity, but the effect on tPA was more variable. This study has shown that TGF‐β has opposite effects on the PA activity of the two osteoblast‐like cell types studied. Care must therefore be used before extrapolating data from one cell type to another. It is suggested that under certain circumstances TGF‐β may be involved in bone resorption by modulating PA activity.
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Orthopedics and Sports Medicine